Get started
Author

Kamala Nola

Observed names: K Nola, Kamala M. Nola, Kamala McMillan Nola
Institution: Lipscomb University
Observed institution: Lipscomb University
ORCID: 0000-0002-3717-1837
Observed ORCID: 0000-0002-3717-1837
OpenAlex ID: A5002005335
Clinical and Humanistic Outcomes of a Lipid Management Program in the Community Pharmacy Setting
2000 · Kamala McMillan Nola, Dick R. Gourley, et al. · Journal of the American Pharmaceutical Association (1996) · 70
The Science Behind Biosimilars
2018 · S. Louis Bridges, Douglas W. White, et al. · Arthritis & Rheumatology · 42
PDF
Data‐Driven Patient Clustering and Differential Clinical Outcomes in the Brigham and Women’s Rheumatoid Arthritis Sequential Study Registry
2020 · Jeffrey R. Curtis, Michael Weinblatt, et al. · Arthritis Care & Research · 30
PDF
Methods for Developing the American College of Rheumatology's Electronic Clinical Quality Measures
2016 · Jinoos Yazdany, Rachel Myslinski, et al. · Arthritis Care & Research · 17
Incorporating the Treat-to-Target Concept in Rheumatoid Arthritis
2012 · Eric M. Ruderman, Kamala M. Nola, et al. · Journal of Managed Care Pharmacy · 17
PDF
The Importance of Authentic Leadership to all Generations Represented within Academic Pharmacy
2018 · Nicole R. Pinelli, Julie M. Sease, et al. · American Journal of Pharmaceutical Education · 13
PDF
Status of diabetes care among community pharmacy patients with diabetes: Analysis of the Medical Expenditure Panel Survey
2010 · Junling Wang, Jeremy Thomas, et al. · Journal of the American Pharmacists Association · 9
Real-World Dose Modification Patterns of Subcutaneous Tocilizumab Among Patients with Rheumatoid Arthritis.
2019 · Rajeshwari Punekar, Jeannie Choi, et al. · PubMed Central · 2
Op0122 Exploring Heterogeneity in Rheumatoid Arthritis: Patient Profiling Through Principal Component and Cluster Analysis of the Brass Registry
2019 · Jeffrey R. Curtis, Michael E. Weinblatt, et al. · Annals of the Rheumatic Diseases · 1
PDF
Sat0599 Exploring Heterogeneity in Rheumatoid Arthritis: Outcomes up to 4 Years of Follow-up in Patient Clusters Identified by Data-driven Analysis of the Brass Registry
2019 · Jeffrey R. Curtis, Michael E. Weinblatt, et al. · Annals of the Rheumatic Diseases · 1
That’s SLiCk! - A Learning Community Approach to Supplemental Instruction
2023 · Sarah P. Collier, Todd Beard, et al. · American Journal of Pharmaceutical Education
Pdb50 Status of Diabetes Control Among Community Pharmacy Users With Diabetes: an Analysis of the Medical Expenditure Panel Survey
2009 · J Wang, J Thomas, et al. · Value in Health
PDF
Works count: 13
Citation count: 202
H-index: 7
I10-index: 6
Year
Topic
Type